<DOC>
	<DOC>NCT00443391</DOC>
	<brief_summary>The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in adults with ADHD.</brief_summary>
	<brief_title>A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>The subject was randomized into Study M06855 and completed treatment in Periods 1 and 2 and the 2week Extension Period If female, subject must be either postmenopausal for at least 1 year, surgically sterile (bilateral tubal ligation, bilateral oophorectomy or hysterectomy), or practicing at least a method of birth control throughout the study If female, the result of a pregnancy tests are negative The subject is judged to be in generally good health More than 7 days have elapsed since the last dose of study drug in Study M06855 The subject has taken any ADHD medication between the last dose of study drug in Study M06855 and the first dose of study drug in the current study The subject anticipates a move outside the geographic area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>ADHD</keyword>
</DOC>